Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 2Brain Neoplasms 1

Interventions

Temozolomide 610Radiotherapy 388Bevacizumab 254Magnetic Resonance Spectroscopy 203Cyclophosphamide 177Carboplatin 159Radiosurgery 146Etoposide 132Radiation 121Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 82Lomustine 81Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Lacosamide × CNS × Clear all
NCT03436433 2023-04-13

Seizure Prophylaxis in Patients With Glioma or Brain Metastasis

Duke University

Phase 2 Terminated
4 enrolled 8 charts
CNS

Brain Neoplasms, Glioma

NCT01432171 2018-12-19

Lacosamide in Preventing Seizures in Participants With Malignant Glioma

M.D. Anderson Cancer Center

Phase NA Terminated
37 enrolled 11 charts
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡